SPR301 is a potential best-in-class gene therapy candidate that delivers a more stable, rationally engineered version of GCase, the enzyme ...

The U.S. Food and Drug Administration has approved PTC Therapeutics' Kebilidi (eladocagene exuparvovec-tneq) for the ...

Studying patients with PD-1 or PD-L1 deficiency may help inform new approaches to fine-tuning immunotherapies to maximise ...

New insights into the impact of checkpoint inhibitors on the immune system may enhance cancer treatment strategies. A ...

Abbisko Cayman Limited (HK:2256) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks ...

The study uncovers genetic factors driving early type 2 diabetes in South Asians, highlighting risks of insulin dependence and medication response challenges.

Sep. 9, 2024 — Researchers tested a preclinical model for an experimental gene therapy designed to treat multiple sulfatase deficiency (MSD), a disorder that affects the brain, lungs ...

Researchers from Queen Mary University, UK, said that while South Asians are known to develop diabetes early in life and ...

Researchers at Osaka University identified a degradation factor for SREBP1 as essential for maintaining the balance of ...

Since the first cases of HIV-1 were reported over 40 years ago, approximately 84·2 million people have been infected and 40·1 ...